Crossmark

Hsa_circ_0003176: a key player in the m6A modification-mediated regulation of autophagy and glycolysis in cisplatin-resistant non-small cell lung cancer

Crossref DOI link: https://doi.org/10.1007/s13577-026-01350-y

Published Online: 2026-01-24

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Guo, Sujuan

Yang, Zhicheng

Qiao, Jiajie

Rong, Lei https://orcid.org/0009-0007-7877-4005
Funding

Funding for this research was provided by:

Shenzhen Science and Technology Program (No.JCY2022053142211026)
License Information

Text and Data Mining valid from 2026-01-24

Version of Record valid from 2026-01-24
More Information

Article History

Received: 4 September 2025

Accepted: 10 January 2026

First Online: 24 January 2026

Declarations

:

: The authors declare no conflicts of interest.

: The study involving human cell lines and animal experiments was conducted in accordance with the guidelines of the Declaration of Helsinki and was approved by the Ethics Committee of the University of Hong Kong-Shenzhen Hospital. All animal experiments were reviewed and approved by the Animal Ethical Committee of the University of Hong Kong-Shenzhen Hospital. The study was carried out in compliance with the ARRIVE guidelines for reporting animal experiments.

: Not applicable.

Document is current

Any future updates will be listed below